However, further molecular and cellular analysis is yet to be performed to identify the underlying mechanisms of lncRNA DLEU2/ROR1 mediated BC progression and metastasis, which may lead to novel therapeutic strategies and predictive and prognostic biomarkers. This evidence concerns the gene DLEU2 and breast cancer.